Total Payments
$5,614
2024 Payments
$1,184
Companies
35
Transactions
302
Medicare Patients
1,049
Medicare Billing
$92,336
Payment Breakdown by Category
Food & Beverage$5,543 (98.7%)
Gifts$59.40 (1.1%)
Education$11.71 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,543 | 300 | 98.7% |
| Gift | $59.40 | 1 | 1.1% |
| Education | $11.71 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,178 | 78 | $0 (2024) |
| Novo Nordisk Inc | $1,038 | 59 | $0 (2024) |
| Abbott Laboratories | $662.15 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $529.54 | 30 | $0 (2024) |
| Medtronic, Inc. | $397.46 | 7 | $0 (2024) |
| ABBVIE INC. | $199.03 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $186.56 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $171.51 | 9 | $0 (2024) |
| Mannkind Corporation | $123.34 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $104.13 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,184 | 58 | Lilly USA, LLC ($250.52) |
| 2023 | $2,011 | 104 | Lilly USA, LLC ($472.37) |
| 2022 | $1,379 | 89 | Novo Nordisk Inc ($279.03) |
| 2021 | $1,040 | 51 | Novo Nordisk Inc ($387.63) |
All Payment Transactions
302 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: DIABETES | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $34.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardio-renal | ||||||
| 10/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $157.16 | General |
| Category: Durable Pump | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Biological | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.15 | General |
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $23.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: DIABETES MEDICINE | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 296 | 495 | $61,579 | $24,234 |
| 2022 | 4 | 268 | 478 | $59,843 | $24,895 |
| 2021 | 4 | 273 | 416 | $53,621 | $24,799 |
| 2020 | 4 | 212 | 343 | $48,381 | $18,407 |
Total Patients
1,049
Total Services
1,732
Medicare Billing
$92,336
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 243 | $42,366 | $17,704 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 38 | $9,248 | $3,584 | 38.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 46 | 79 | $6,320 | $1,691 | 26.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 91 | 135 | $3,645 | $1,255 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 251 | $43,423 | $18,706 | 43.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 31 | $7,471 | $3,383 | 45.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 39 | 69 | $5,520 | $1,596 | 28.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 83 | 127 | $3,429 | $1,210 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 194 | $33,070 | $16,267 | 49.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 49 | $11,418 | $5,572 | 48.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 33 | 56 | $4,428 | $1,313 | 29.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 76 | 106 | $2,862 | $1,029 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 11 | $1,843 | $617.13 | 33.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 195 | $32,565 | $12,729 | 39.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 51 | $11,424 | $4,227 | 37.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 18 | 35 | $2,718 | $853.30 | 31.4% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 47 | 62 | $1,674 | $598.22 | 35.7% |
About Katie Casey, NP-C
Katie Casey, NP-C is a Family healthcare provider based in Festus, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1225452501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katie Casey, NP-C has received a total of $5,614 in payments from pharmaceutical and medical device companies, with $1,184 received in 2024. These payments were reported across 302 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,543).
As a Medicare-enrolled provider, Casey has provided services to 1,049 Medicare beneficiaries, totaling 1,732 services with total Medicare billing of $92,336. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Festus, MO
- Active Since 02/07/2014
- Last Updated 01/23/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1225452501
Products in Payments
- MOUNJARO (Drug) $519.15
- TRULICITY (Drug) $480.37
- FARXIGA (Drug) $447.81
- Ozempic (Drug) $333.74
- Rybelsus (Drug) $295.12
- RYBELSUS (Drug) $293.84
- MINIMED 780G (Device) $266.46
- FREESTYLE LIBRE 2 (Device) $249.50
- FREESTYLE LIBRE 3 (Device) $245.64
- JARDIANCE (Drug) $198.49
- Kerendia (Drug) $186.56
- AFREZZA (Drug) $123.34
- CARDIOMEMS (Device) $123.02
- UBRELVY (Drug) $96.70
- BREZTRI (Drug) $81.73
- Otezla (Drug) $76.25
- Korlym (Drug) $76.11
- SOLIQUA 100/33 (Biological) $71.12
- MINIMED 770G (Device) $69.55
- EMGALITY (Drug) $64.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Festus
Kristen Rider, Aprn, Np-C, APRN, NP-C
Family — Payments: $10,789
Family $10,789
Mrs. Lacy Hosay, Fnp-Bc, FNP-BC
Family — Payments: $9,146
Family $9,146
Katelyn Coleman, Fnp-Bc, FNP-BC
Family — Payments: $4,055
Family $4,055
Jolene Cabral, Fnp, FNP
Family — Payments: $4,021
Family $4,021
Ashley Davis, Fnp-C, FNP-C
Family — Payments: $2,758
Family $2,758
Andrea Bova
Family — Payments: $2,542
Family $2,542